Yuanbo Lan

Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database

Fan Zou, Zhiwei Cui, Siyu Lou et al. · Frontiers in Pharmacology · 2024 · 97 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study

Shun Lü, Jianying Zhou, Hong Jian et al. · The Lancet Respiratory Medicine · 2023 · 71 citations

Medicine, Oncology, Pharmacology +14

A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database

Fan Zou, Chengyu Zhu, Siyu Lou et al. · Frontiers in Pharmacology · 2023 · 57 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Drug resistance profiles and trends in drug-resistant tuberculosis at a major hospital in Guizhou Province of China

Yuanbo Lan, Yuqin Li, Ling Chen et al. · Infection and Drug Resistance · 2019 · 21 citations · Full text

Medicine, Pharmacology, Antimicrobial Resistance +16

<p>Resistance To First-Line Antituberculosis Drugs And Prevalence Of <em>pncA</em> Mutations In Clinical Isolates Of <em>Mycobacterium tuberculosis</em> From Zunyi, Guizhou Province Of China</p>

Zhimin Cao, Yuanbo Lan, Ling Chen et al. · Infection and Drug Resistance · 2019 · 11 citations · Full text

Medicine, Pharmacology, Antimicrobial Pharmacotherapy +12